Sciencast Management’s TechnipFMC FTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.07M Buy
+31,251
New +$2.21M 0.43% 102
2025
Q3
Sell
-116,138
Closed -$4M 313
2025
Q2
$4M Buy
116,138
+67,434
+138% +$2.03M 0.83% 18
2025
Q1
$1.54M Sell
48,704
-52,848
-52% -$1.58M 0.36% 123
2024
Q4
$2.94M Buy
101,552
+84,661
+501% +$2.41M 0.8% 47
2024
Q3
$443K Sell
16,891
-37,365
-69% -$990K 0.13% 187
2024
Q2
$1.42M Buy
54,256
+12,095
+29% +$312K 0.49% 95
2024
Q1
$1.06M Buy
42,161
+31,113
+282% +$655K 0.65% 59
2023
Q4
$223K Sell
11,048
-1,152
-9% -$23.6K 0.12% 196
2023
Q3
$248K Sell
12,200
-25,510
-68% -$481K 0.11% 259
2023
Q2
$647K Buy
+37,710
New +$532K 0.53% 77
2019
Q4
Sell
-30,554
Closed -$532K 516
2019
Q3
$532K Buy
+30,554
New +$570K 0.18% 198
2019
Q2
Sell
-11,558
Closed -$214K 350
2019
Q1
$214K Buy
+11,558
New +$195K 0.08% 323

Other funds holding FTI

Sciencast Management's FTI Position: Q2 2026 in Review

Sciencast Management opened a new position in TechnipFMC (FTI) in Q2 2026: 31,251 shares worth $2.07M. The stake represents 0.43% of the portfolio and ranks #102 among its holdings. This is a return to the name: Sciencast Management previously reported a position in FTI as recently as Q2 2025.

Sciencast Management first reported a position in FTI in Q1 2019 and has held it in 12 quarters since. The position peaked at $4M in Q2 2025. 819 funds tracked by Wall St. Rank hold FTI as of Q2 2026.

  • Sciencast Management held 31,251 shares of TechnipFMC worth $2.07M as of Q2 2026.
  • TechnipFMC was a new Sciencast Management position in Q2 2026.
  • TechnipFMC made up 0.43% of Sciencast Management's portfolio in Q2 2026, its #102 holding.
  • Sciencast Management first reported a position in TechnipFMC in Q1 2019 and has held it in 12 quarters since.
  • Sciencast Management's TechnipFMC position peaked at $4M in Q2 2025.
  • 819 funds tracked by Wall St. Rank held TechnipFMC as of Q2 2026.

Based on Sciencast Management's 13F filing for Q2 2026, filed 28 Jul 2026.